Skip to content

BioLizard chooses Biopôle for its Swiss subsidiary

Share this article

BioLizard is a Belgian bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life sciences industry.



Liesbeth Ceelen, PhD, CEO of BioLizard, said: “We aim to meet the need for expertise and tools for digital transformation of biotech companies, including for AI-enabled, user-friendly software and data infrastructure. (…) We leverage the unique knowledge of our team to support the therapeutics, diagnostics, animal health and food & agriculture industries. Biopôle houses 120 companies and provides great conditions for us to engage with the Swiss biotech industry.”


“Switzerland plays a leading role in driving global healthcare innovation, with 20% of European biotech companies headquartered in Switzerland and R&D investments reaching a record level of CHF 2.7 billion in 2022”, added Yves Muyssen, COO of BioLizard. “Biopôle fosters innovation by combining a number of diverse life sciences companies, ranging from small to large, pre-clinical to clinical, and research to service. We know from our clients that IT- and AI-based data solutions have become of paramount importance to drive research forward by accelerating speed, decreasing risk and improving quality of results. With this new subsidiary, we look forward to supporting new and existing partners and thereby contributing to the Swiss biotech landscape.”


Source: Press Release